Skip to main content
. Author manuscript; available in PMC: 2017 Dec 21.
Published in final edited form as: ACS Chem Neurosci. 2016 Oct 5;7(12):1706–1716. doi: 10.1021/acschemneuro.6b00230

Figure 4.

Figure 4

Novel object recognition deficit of NR1 KD mice is reversed by M1 PAM administration. NR1 KD animals showed no preference for the novel object when treated with vehicle. Pretreatment with VU6004256 resulted in dose-dependent increases in recognition index. Acute treatment with 10 mg/kg VU6004256 in WT animals resulted in an increase in recognition index (n = 8–10/treatment group, * p < 0.05, two-way ANOVA followed by Bonferroni’s post hoc test).

HHS Vulnerability Disclosure